Skip to content

Comparative Managment of Amavata (Rheumatoid Arthritis) through Pathyadi Churna and Bhagottara Churna

ETIOPATHOLOGICAL STUDY OF AMAVATA W.S.R. TO RHEUMATOID ARTHRITIS AND COMPARATIVE THERAPEUTICAL EFFECT OF PATHYADI CHURNA AND BHAGOTTARA CHURNA - NIL

Status
Active, not recruiting
Phases
Phase 2Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/04/085579
Enrollment
60
Registered
2025-04-24
Start date
Unknown
Completion date
Unknown
Last updated
2025-04-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: M057- Rheumatoid arthritis with rheumatoid factor without organ or systems involvement

Interventions

None listed

Sponsors

Madan Mohan Malviya Government Ayurved College
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Individuals of either sex between the age group 20 to 70 years Individual who are willing to give consent for the study Patients having Lakshanas of Amavata were considered for the present study Patients who fall under the Eular Criteria 2020 for Rheumatoid Arthritis

Exclusion criteria

Exclusion criteria: Individuals with age below 20 years and above 70 years Patients having serious systemic illness Patients having joint pathologies other than Rheumatoid Arthritis

Design outcomes

Primary

MeasureTime frame
Improvement in sign and symptoms of Amavata (Rheumatoid Arthritis)Timepoint: 30 days

Secondary

MeasureTime frame
Improvement in sign & symptoms of Amavata (Rheumatoid Arthritis)Timepoint: 15th day 30th day

Countries

India

Contacts

Public ContactDr Ved Prakash

Madan Mohan Malviya Government Ayurved College

ved18061985@rediffmail.com9414664088

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026